Sustained proliferation and resistance to apoptosis after a cytotoxic insult are early alterations in rat colon carcinogenesis

International Journal of Cancer

Volumn 131, Issue 3, 2012, Pages 529-536

  Femia, Angelo Pietro ^a   Salvianti, Francesca ^a   Luceri, Cristina ^a   Dolara, Piero ^a   Salvadori, Maddalena ^a   Pinzani, Pamela ^a   Caderni, Giovanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

apoptosis; aspirin; colon carcinogenesis; mucin depleted foci; preneoplastic lesions; proliferation; survivin

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ACETYLSALICYLIC ACID; MESSENGER RNA; PROSTAGLANDIN E2; PROTEIN BAK; SURVIVIN;

ABERRANT CRYPT FOCUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLON CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; GENE; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MUCIN DEPLETED FOCUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRECANCER; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVIN GENE;

1,2-DIMETHYLHYDRAZINE; ANIMALS; APOPTOSIS; ASPIRIN; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CASPASE 3; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; DINOPROSTONE; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MUCINS; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; TUMOR MARKERS, BIOLOGICAL;

EID: 84861561353     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26406     Document Type: Article

References (45)

1. Koornstra JJ, de Jong S, Hollema H, de Vries EG, Kleibeuker JH,. Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature. Crit Rev Oncol Hematol 2003; 45: 37-53.
2. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
3. Sena P, Roncucci L, Marzona L, Mariani F, Maffei S, Manenti A, De Pol A,. Cancer Epidemiol Biomarkers Prev 2010; 19: 351-7. Erratum in: Cancer Epidemiol Biomarkers Prev 2010; 19: 1886.
4. Anti M, Armuzzi A, Morini S, Iascone E, Pignataro G, Coco C, Lorenzetti R, Paolucci M, Covino M, Gasbarrini A, Vecchio F, Gasbarrini G,. Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas. Gut 2001; 48: 238-46.
5. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC,. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996; 56: 2422-7.
6. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ,. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995; 55: 1811-6.
7. Magnuson BA, Shirtliff N, Bird RP,. Resistance of aberrant crypt foci to apoptosis induced by azoxymethane in rats chronically fed cholic acid. Carcinogenesis 1994; 15: 1459-62.
8. Wargovich MJ, Medline A, Bruce WR,. Early histopathologic events to evolution of colon cancer in C57BL/6 and CF1 mice treated with 1,2-dimethylhydrazine. J Natl Cancer Inst 1983; 71: 125-31.
9. Lipkin M,. Biomarkers of increased susceptibility to gastrointestinal cancer: new applications to studies of cancer prevention in human subjects. Cancer Res 1988; 48: 235-45.
10. Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, Salvadori M, Dolara P,. Identification of mucin-depleted foci (MDF) in the unsectioned colon of azoxymethane (AOM)-treated rats: correlation with carcinogenesis. Cancer Res 2003; 63: 2388-2392.
11. Femia AP, Bendinelli B, Giannini A, Salvadori M, Pinzani P, Dolara P, Caderni G,. Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats. Int J Cancer 2005; 116: 9-15
12. Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri DC,. Survivin and molecular pathogenesis of colorectal cancer. Lancet 2003; 362: 205-9.
13. Zhang T, Otevrel T, Gao Z, Gao Z, Ehrlich SM, Fields JZ, Boman BM,. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 2001; 61: 8664-7.
14. Pennati M, Folini M, Zaffaroni N,. Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 2007; 28: 1133-1139.
15. Duckworth CA, Pritchard DM,. Suppression of apoptosis, crypt hyperplasia, and altered differentiation in the colonic epithelia of bak-null mice. Gastroenterology 2009; 136: 943-52.
16. Femia AP, Dolara P, Luceri C, Salvadori M, Caderni G,. Mucin-depleted foci show strong activation of inflammatory markers in 1,2-dimethylhydrazine- induced carcinogenesis and are promoted by the inflammatory agent sodium dextran sulfate. Int J Cancer 2009; 125: 541-7.
17. Kundu JK, Surh YJ,. Inflammation: gearing the journey to cancer. Mutat Res 2008; 659: 15-30.
18. European Community: European Community Regulations on the Care and Use of Laboratory Animals (1986) (Law 86/609/EC).
19. Femia AP, Dolara P, Giannini A, Salvadori M, Biggeri A, Caderni G,. Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis. Cancer Res 2007; 67: 445-9.
20. Caderni G, De Filippo C, Luceri C, Salvadori M, Giannini A, Biggeri A, Remy S, Cheynier V, Dolara P,. Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis 2000; 21: 1965-9.
21. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G,. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002; 23: 1953-60
22. Schmittgen TD, Livak KJ,. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-8.
23. Luceri C, Caderni G, Sanna A, Dolara P,. Red wine and black tea polyphenols modulate the expression of cycloxygenase-2, inducible nitric oxide synthase and glutathione-related enzymes in azoxymethane-induced F344 rat colon tumours. J Nutr 2002; 132: 1376-9.
24. Femia AP, Giannini A, Fazi M, Tarquini M, Salvadori M, Roncucci L, Tonelli F, Dolara P, Caderni G,. Identification of mucin depleted foci in the human colon. Cancer Prev Res 2008; 1: 562-567.
25. Kozoni V, Tsioulias G, Shiff S, Rigas B,. The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: differential effect on apoptosis in the presence of a colon carcinogen. Carcinogenesis 2000; 21: 999-1005
26. Guda K, Marino JN, Jung Y, Crary K, Dong M, Rosenberg DW,. Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice. Int J Oncol 2007; 31: 837-42.
27. Tessitore L, Davit A, Sarotto I, Caderni G,. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 2000; 21: 1619-22
28. Corpet DE, Taché S, Peiffer G,. Colon tumor promotion: is it a selective process? Effects of cholate, phytate, and food restriction in rats on proliferation and apoptosis in normal and aberrant crypts. Cancer Lett 1997; 114: 135-8
29. Latham P, Lund EK, Johnson IT,. Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis 1999; 20: 645-50
30. Zeilstra J, Joosten SP, Wensveen FM, Dessing MC, Schütze DM, Eldering E, Spaargaren M, Pals ST,. WNT signaling controls expression of pro-apoptotic BOK and BAX in intestinal cancer. Biochem Biophys Res Commun 2011; 406: 1-6.
31. Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R, Besselsen DG, Godfrey VL, Doetschman T, Dove WF, Pitot HC, Halberg RB, Itzkowitz SH, Groden J, Coffey RJ,. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003; 124: 762-77.
32. Holubec H, Payne CM, Bernstein H, Dvorakova K, Bernstein C, Waltmire CN, Warneke JA, Garewal H,. Assessment of apoptosis by immunohistochemical markers compared to cellular morphology in ex vivo-stressed colonic mucosa. J Histochem Cytochem 2005; 53: 229-35.
33. Femia AP, Caderni G, Bottini C, Salvadori M, Dolara P, Tessitore L,. Mucin-depleted foci are modulated by dietary treatments and show deregulation of proliferative activity in carcinogen-treated rodents. Int J Cancer 2007; 120: 2301-5.
34. Roncucci L, Pedroni M, Vaccina F, Benatti P, Marzona L, De Pol A,. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif 2000; 33: 1-18.
35. Velmurugan B, Singh RP, Agarwal R, Agarwal C,. Dietary-feeding of grape seed extract prevents azoxymethane-induced colonic aberrant crypt foci formation in fischer 344 rats. Mol Carcinog 2010; 49: 641-52.
36. Bhatnagar N, Li X, Chen Y, Zhou X, Garrett SH, Guo B,. 3,3'-Diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin. Cancer Prev Res (Phila) 2009; 2: 581-9.
37. Susnow NJ, Hockenbery DM,. Bak to basics of colonocyte renewal. Gastroenterology 2009; 136: 763-6.
38. Itzkowitz SH, Yio X,. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G7-17.
39. Reddy BS, Maruyama H, Kelloff G,. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res 1987; 47: 5340-46.
40. Warren CA, Paulhill KJ, Davidson LA, Lupton JR, Taddeo SS, Hong MY, Carroll RJ, Chapkin RS, Turner ND,. Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis. J Nutr 2009; 139: 101-5.
41. Jia Q, Lupton JR, Smith R, Weeks BR, Callaway E, Davidson LA, Kim W, Fan YY, Yang P, Newman RA, Kang JX, McMurray DN, Chapkin RS,. Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res 2008; 68: 3985-91.
42. Hu Y, Le Leu RK, Young GP,. Sulindac corrects defective apoptosis and suppresses azoxymethane-induced colonic oncogenesis in p53 knockout mice. Int J Cancer 2005; 116: 870-5.
43. Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ,. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res 1997; 57: 2452-9.
44. Thun MJ, Henley SJ, Patrono C,. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002; 94: 252-66.
45. Kapetanovic IM, Bauer KS, Tessier DM, Lindeblad MO, Zakharov AD, Lubet R, Lyubimov A,. Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats. Chem Biol Interact 2009; 179: 233-9.